Adults 18 to 80, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Sensitivity of INVSENSOR00027's Posture Change DetectionPrimary· 1-5 hours
For each subject's position detection, INVSENSOR00027 output will be compared against observer's notes at each turn of the subject. Correctly detected position changes will be marked as True Positive. Missed detections (if any) will be counted. The sensitivity of INVSENSOR00027's posture change detection will be computed as Sensitivity = True Positive/(True Positive+Missed Detection)
Group
Value
95% CI
INVSENSOR00027 Test Group
100
Sensitivity of INVSENSOR00027's Activity Change DetectionPrimary· 1-5 hours
For each subject's activity (e.g., walking and upright) detection, INVSENSOR00027 output will be compared against observer's notes. Correctly detected activity changes will be marked as True Positive. Missed detections (if any) will be counted. The sensitivity of INVSENSOR00027's activity change detection will be computed as Sensitivity = True Positive/(True Positive+Missed Detection).
Group
Value
95% CI
INVSENSOR00027 Test Group
96.7
Sensitivity of INVSENSOR00027's Fall Event DetectionPrimary· 1-5 hours
Group
Value
95% CI
INVSENSOR00027 Test Group
100
Respiratory Rate DetectionSecondary· 1-5 hours
Accuracy will be determined by comparing the respiratory rate measurement of the INVSENSOR00027 to the respiratory rate reference (RRef) and calculating the arithmetic root mean square (Arms) value. In order to obtain the Arms value, the RR measurement from the reference is subtracted from the INVSENSOR00027 RR measurement for a number of samples. The average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the Arms value.
Group
Value
95% CI
INVSENSOR00027 Test Group
1.7
Sponsor's own description
This study assesses the investigational sensor's (INVSENSOR00027) performance for detection of subjects' position and posture in bed, along with heart rate and respiratory rate.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT04224753 — INVSENSOR00027 Fall Detection Clinical Performance Study
· NA
· completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
NCT06707207 — Predicting Future Errors During Skill Performance
· recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
· Phase 1
· recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
· NA
· recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects
· NA
· recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity
· Phase 1, PHASE2
· recruiting
Other Masimo Corporation trials
Trials by the same sponsor.
NCT07223177 — Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations
· NA
· recruiting
NCT07223164 — Validation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease
· NA
· recruiting
NCT06334055 — Validation Study of Mean Arterial Pressure (MAP) Parameter of Masimo INVSENSOR00073
· NA
· completed
NCT06432881 — Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)
· NA
· recruiting
NCT06148623 — Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation
· NA
· completed
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Masimo Corporation
Last refreshed: 29 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03650192.